ArticleVaccines2022

Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling.

Chao-Hung Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.